Bispecific Antibodies Market, By Drug Type (Immunoglobulin G and Non-Immunoglobulin G), By Indication, By Distribution Channel, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4090
|
Published Date
July 2025
|
Pages
303
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Bispecific antibodies market size was valued at US$ 10,992.09 Million in 2024, expanding at a CAGR of 40.10% from 2025 to 2032.
Bispecific antibodies are engineered proteins capable of simultaneously recognizing and binding to two different antigens. Unlike traditional monoclonal antibodies, which target a single molecule, bispecific antibodies can engage two distinct targets—such as a cancer cell and a T-cell—thereby enhancing the immune response and increasing therapeutic precision. This dual-targeting capability makes them particularly effective in treating complex diseases like cancer, autoimmune disorders, and infectious diseases, providing improved treatment outcomes while minimizing off-target effects.
Bispecific Antibodies Market- Market Dynamics
Rising FDA approvals are expected to drive market growth.
The growing approval of bispecific therapies is fueling market expansion, with the U.S. FDA granting approval to six bispecific antibodies between 2022 and 2024, demonstrating increasing regulatory support for innovative cancer treatments. Additionally, the rising global cancer burden—estimated by the World Health Organization to cause nearly 10 million deaths annually—accelerates demand for advanced immunotherapies, driving investment in targeted therapeutics like bispecific antibodies. However, complex manufacturing processes and high development costs remain significant challenges to market growth. Conversely, expanding government funding for cancer research worldwide, including over USD 15 billion allocated by the U.S. National Cancer Institute in 2023, is boosting innovation potential and creating substantial growth opportunities for the global bispecific antibodies market.
Bispecific Antibodies Market- Segmentation Analysis:
The Global Bispecific Antibodies Market is segmented on the basis of Drug Type, Indication, Distribution Channel, and Region.
The market for bispecific antibodies is segmented based on indication into inflammatory and autoimmune disorders, cancer, and others. Among these, the cancer segment is expected to hold the largest market share during the forecast period. This dominance is primarily driven by the increasing global cancer burden and the significant clinical success of bispecific antibodies, which effectively target tumor cells while simultaneously activating immune responses to enhance treatment efficacy. According to the World Health Organization (WHO), cancer remains one of the leading causes of death worldwide, with an estimated 19.3 million new cases and nearly 10 million deaths reported in 2023. Governments are intensifying efforts to combat cancer through advanced therapeutics, fueling strong demand for innovative treatments like bispecific antibodies.
In terms of distribution channels, the market is divided into drug stores, retail pharmacies, hospital pharmacies, and online pharmacies. The hospital pharmacies segment is expected to dominate the market, as bispecific antibodies are primarily administered for complex conditions such as cancer and autoimmune diseases that require specialized handling, administration, and continuous monitoring. Hospital settings provide the necessary infrastructure for inpatient care and management of potential adverse effects associated with these therapies. The U.S. Food and Drug Administration (FDA) reported that over 70% of oncology biologics are dispensed through hospital pharmacies, reflecting the critical role of these facilities in delivering advanced cancer treatments safely and effectively.
Bispecific Antibodies Market- Geographical Insights
North America is expected to dominate the global bispecific antibodies market during the forecast period, supported by its advanced healthcare infrastructure, substantial R&D investments, and early regulatory approvals from agencies like the U.S. FDA. For instance, according to the U.S. National Cancer Institute, federal funding for cancer research reached approximately USD 7.9 billion in 2023, fueling innovation in targeted therapies including bispecific antibodies. Meanwhile, the Asia-Pacific region is projected to experience the fastest growth, driven by rising cancer prevalence, increased clinical trial activities, expanding healthcare access, and growing investments in the biopharmaceutical sector in countries such as China, India, and South Korea, where governments are also increasing healthcare spending to combat the rising disease burden.
Bispecific Antibodies Market- Competitive Landscape:
The growing demand for targeted immunotherapies is intensifying competition in the bispecific antibodies market, driving companies to focus on innovation, clinical development, and securing regulatory approvals. Firms are heavily investing in R&D to develop improved bispecific antibody formats that offer enhanced safety profiles and increased efficacy in treating cancer and autoimmune diseases. Strategic collaborations, licensing agreements, and expansion into emerging markets are also key strategies employed to strengthen market presence. Additionally, companies are leveraging advanced platforms and proprietary technologies to accelerate their pipelines and gain a sustainable competitive edge in this rapidly evolving therapeutic landscape.
Recent Developments:
- In March 2025, SanyouBio launched 73 bispecific antibody reference products, covering both approved and clinical-stage drugs. This initiative aims to support drug development by enabling dual-target binding to overcome challenges such as resistance associated with single-target therapies.
- In April 2025, Invenra Inc. introduced its B-Body Express™ Antibody Expression service, providing biotech and pharmaceutical companies with rapid access to high-purity, validated bispecific antibodies derived from partner sequences, thereby accelerating preclinical research through advanced technology and increased speed.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BISPECIFIC ANTIBODIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Amgen
- Genentech
- Akeso, Inc.
- Taisho Pharmaceutical
- Janssen
- Immunocore
- Adimab, Innovent Biologics, Inc.
- AstraZeneca
- Affimed GmbH
- Xencor
- F. Hoffmann-La Roche Ltd.
- Sanofi
- Regeneron Pharmaceuticals Inc.
- Pieris Pharmaceuticals, Inc.
- Eli Lilly
- Mereo BioPharma Group plc
- Merus
- MacroGenics, Inc.
- Sobi, TG Therapeutics Inc.
- Genmab A/S
- Alteogen
- Emergent BioSolutions Inc.
- Novartis AG
- Astellas Pharma Inc.
- Celgene Corporation
- Others
GLOBAL BISPECIFIC ANTIBODIES MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032
- Immunoglobulin G
- Non-Immunoglobulin G
GLOBAL BISPECIFIC ANTIBODIES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
- Inflammatory & Autoimmune Disorder
- Cancer
- Others
GLOBAL BISPECIFIC ANTIBODIES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Drug Stores
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
GLOBAL BISPECIFIC ANTIBODIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Bispecific Antibodies Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Bispecific Antibodies Market Snippet by Drug Type
2.1.2. Bispecific Antibodies Market Snippet by Indication
2.1.3. Bispecific Antibodies Market Snippet by Distribution Channel
2.1.4. Bispecific Antibodies Market Snippet by Country
2.1.5. Bispecific Antibodies Market Snippet by Region
2.2. Competitive Insights
3. Bispecific Antibodies Key Market Trends
3.1. Bispecific Antibodies Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Bispecific Antibodies Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Bispecific Antibodies Market Opportunities
3.4. Bispecific Antibodies Market Future Trends
4. Bispecific Antibodies Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Bispecific Antibodies Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Bispecific Antibodies Market Landscape
6.1. Bispecific Antibodies Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Bispecific Antibodies Market – By Drug Type
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Type, 2024 & 2032 (%)
7.1.2. Immunoglobulin G
7.1.3. Non-immunoglobulin G
8. Bispecific Antibodies Market – By Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
8.1.2. Inflammatory & Autoimmune Disorder
8.1.3. Cancer
8.1.4. Others
9. Bispecific Antibodies Market – By Distribution Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
9.1.2. Drug Stores
9.1.3. Retail Pharmacies
9.1.4. Hospital Pharmacies
9.1.5. Online Pharmacies
10. Bispecific Antibodies Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Bispecific Antibodies Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Bispecific Antibodies Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Bispecific Antibodies Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Bispecific Antibodies Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Bispecific Antibodies Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Bispecific Antibodies Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Amgen
11.2.2. Genentech
11.2.3. Akeso, Inc.
11.2.4. Taisho Pharmaceutical
11.2.5. Janssen
11.2.6. Immunocore
11.2.7. Adimab, Innovent Biologics, Inc.
11.2.8. AstraZeneca
11.2.9. Affimed GmbH
11.2.10. Xencor
11.2.11. F. Hoffmann-La Roche Ltd.
11.2.12. Sanofi
11.2.13. Regeneron Pharmaceuticals Inc.
11.2.14. Pieris Pharmaceuticals, Inc.
11.2.15. Eli Lilly
11.2.16. Mereo BioPharma Group plc
11.2.17. Merus
11.2.18. MacroGenics, Inc.
11.2.19. Sobi, TG Therapeutics Inc.
11.2.20. Genmab A/S
11.2.21. Alteogen
11.2.22. Emergent BioSolutions Inc.
11.2.23. Novartis AG
11.2.24. Astellas Pharma Inc.
11.2.25. Celgene Corporation
11.2.26. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
